Competing risk survival analysis in patients with symptomatic Waldenstrom macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Association does not establish causation. Comment on: “Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopenia”Haematologica · 2026
2Frequent FLT3 and IDH co-mutations in acute myeloid leukemia with mutated NPM1, NUP98 rearrangement, and KMT2A partial tandem duplication but not rearrangement: potential for combined targeted therapyHaematologica · 2026
3Platelet and megakaryocyte function in the pathogenesis of POEMS syndromeHaematologica · 2026
4Salvage-free, transplantation-free survival: a proposal for a new clinical endpoint in acute myeloid leukemiaHaematologica · 2026
5Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed productsHaematologica · 2026
6CD34+-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a large cohort study focusing on haploidentical transplantationHaematologica · 2026
7Distinct clinical and molecular profiles of acute myeloid leukemia defined by mutations in IDH1, IDH2, and TET2Haematologica · 2026
8Depletion of CD19-positive B-cells and dexamethasone premedication may result in immune suppression in patients with B-precursor acute lymphoblastic leukemia after consolidation treatment with blinatumomabHaematologica · 2026
9Prospective study of longitudinal geriatric assessment with risk-adapted interventions for older patients in allogeneic hematopoietic cell transplantationHaematologica · 2026
10The importance of preparation for or achieving accreditation for small and high volume hematopoietic cell transplantation programsHaematologica · 2026

More from Haematologica

More from National and Kapodistrian University of Athens